May 18 Drug wholesaler McKesson Corp reported a 4.4 percent rise in quarterly revenue, helped by strength in its pharmaceutical distribution and services business.
Net income attributable to McKesson rose to $3.59 billion, or $16.76 per share, in the fourth quarter ended March 31, from $431 million, or $1.88 per share, a year earlier.
The latest quarter earnings included a pre-tax net gain of $3.9 billion related to the creation of the Change Healthcare joint venture.
Revenue rose to $48.71 billion from $46.68 billion, the company said on Thursday.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila)
CORRECTED-UPDATE 1-Deadly brain infection in German MS patient prompts Roche investigation
ZURICH, May 24 A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday.
UK says making progress with tech companies on getting encrypted militant messages
LONDON, May 28 Britain is making good progress with technology companies on getting access to the encrypted messages of militant suspects, interior minister Amber Rudd said on Sunday.